← Back to ACHC filing summaryOriginal filing text · Part I
Item 3 — Quantitative and Qualitative Disclosures About Market Risk
Acadia Healthcare Company, Inc. · 10-Q · Q2 FY2026 · Period ended Jun 30, 2026
View complete filing on SEC EDGAR ↗This is the extracted source text from the SEC filing. Formatting may differ from the original document.
Interest Rate Risk
Our interest expense is sensitive to changes in market interest rates. Our long-term debt outstanding at June 30, 2026 was composed of $1,463.5 million of fixed-rate debt and $951.1 million of variable-rate debt with interest based on Adjusted Term SOFR plus an applicable margin. Based on our borrowing level at June 30, 2026, a hypothetical 1% increase in interest rates would decrease our pretax income on an annual basis by approximately $9.5 million.